India to Australia: Sunitinib Export Trade Route
India has recorded 17 verified shipments of Sunitinib exported to Australia, representing a combined trade value of $994.3K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $58.5K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 53% of total export value with 6 shipments worth $531.7K USD. On the buying side, SUN PHARMA ANZ PTY LTD is the largest importer in Australia with $416.6K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , CIPLA LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Sunitinib corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $994.3K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's sunitinib manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $58.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with sunitinib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #20 among India's top sunitinib export destinations globally.
On the import side, key buyers of Indian sunitinib in Australia include SUN PHARMA ANZ PTY LTD , SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD and 1 others. SUN PHARMA ANZ PTY LTD is the single largest importer with 3 shipments valued at $416.6K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#20
- Annual growth+31.8%
- Demand growth+26.5%
- Regulatory ease87/100
Top 10 Indian Sunitinib Exporters to Australia
Showing top 10 of 3 Indian suppliers exporting Sunitinib to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $88.6K per shipment | 6 | $531.7K | 53.5% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $138.9K per shipment | 3 | $416.6K | 41.9% |
| 3 | CIPLA LIMITED Avg $5.7K per shipment | 8 | $46.0K | 4.6% |
This table shows the top 10 of 3 Indian companies exporting sunitinib to Australia, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , CIPLA LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 6 shipments worth $531.7K USD, giving it a 53% market share.
Top 10 Sunitinib Importers in Australia
Showing top 10 of 4 known buyers in Australia receiving Sunitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sunitinib in Australia include SUN PHARMA ANZ PTY LTD , SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD, CIPLA AUSTRALIA PTY LTD. . The largest importer is SUN PHARMA ANZ PTY LTD , accounting for $416.6K USD across 3 shipments — representing 42% of all sunitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMA ANZ PTY LTD | 3 | $416.6K | 41.9% |
| 2 | SUN PHARMA ANZ PTY LIMITED | 3 | $281.5K | 28.3% |
| 3 | SUN PHARMA ANZ PTY LTD | 3 | $250.2K | 25.2% |
| 4 | CIPLA AUSTRALIA PTY LTD. | 8 | $46.0K | 4.6% |
Top 10 Sunitinib Formulations Imported by Australia
Showing top 10 of 13 product formulations shipped on the India to Australia Sunitinib route, ranked by trade value
Australia imports a wide range of sunitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SUNITINIB MALATE CAP 50MG 4X7B AU PACK — accounts for $186.9K USD across 1 shipments. There are 13 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNITINIB MALATE CAP 50MG 4X7B AU PACK | 1 | $186.9K | 18.8% |
| 2 | SUNITINIB MALATE CAP 25MG 4X7B AU PACK | 1 | $147.0K | 14.8% |
| 3 | SUNITINIB MALATE CAP 37.5MG 4X7B AU BATCH : DNE1009A MFD : 07.09.2023 EXP : 31.08.2025 AS PER ATTACHED DOCUMENT | 1 | $111.0K | 11.2% |
| 4 | SUNITINIB MALATE CAP 25MG 4X7B AU BATCH: DNE1008A MFD : 07.09.2023 EXP : 31.08.2025 | 1 | $101.8K | 10.2% |
| 5 | SUNITINIB MALATE CAP 50MG EACH CAPSULE CONTAINS: SUNITINIB MALATE EQUIVALENT TOSUNITINIB 50MG (QTY.338 X 4X7S) | 1 | $99.8K | 10.0% |
| 6 | SUNITINIB MALATE CAP 25MG EACH CAPSULE CONTAINS: SUNITINIB MALATE EQUIVALENT TOSUNITINIB 25MG (QTY. 518 X 4X7S) | 1 | $86.1K | 8.7% |
| 7 | SUNITINIB MALATE CAP 37.5MG 4X7B AU PACK | 1 | $82.8K | 8.3% |
| 8 | SUNITINIB MALATE CAP 50MG 4X7B AUBATCH: DNE1011A MFD : 07.09.2023 EXP : 31.08.2025 | 1 | $68.7K | 6.9% |
| 9 | SUNITINIB MALATE CAP 37.5MG EACH CAPSULECONTAINS: SUNITINIB MALATE EQUIVALENT TO SUNITINIB 37.5MG (QTY. 292 X 4X7S) | 1 | $64.3K | 6.5% |
| 10 | SUNITINIB MSN (50MG HARD CAPSULES)(SUNIT | 2 | $19.4K | 1.9% |
Showing top 10 of 13 Sunitinib formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 11 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's sunitinib exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $58.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as sunitinib malate cap 25mg 4x7b au pack and sunitinib malate cap 37.5mg 4x7b au batch : dne1009a mfd : 07.09.2023 exp : 31.08.2025 as per attached document , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMA ANZ PTY LTD is the largest importer with 3 shipments worth $416.6K USD — representing 42% of all sunitinib imports from India on this route.
Route Statistics
- Trade Volume
- $994.3K
- Avg. Shipment
- $58.5K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~22 days
- Annual Growth
- +31.8%
Reverse Direction
Australia → India — Sunitinib (Import)Other Sunitinib Routes
Unlock the Full India to Australia Sunitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 17 shipments on this route.
Frequently Asked Questions — India to Australia Sunitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sunitinib to Australia?
The leading Indian exporters of Sunitinib to Australia are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , CIPLA LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 53% of total trade value on this route.
Q What is the total value of Sunitinib exports from India to Australia?
India exports Sunitinib to Australia worth approximately $994.3K USD across 17 recorded shipments. The average value per shipment is $58.5K USD.
Q Which ports does India use to ship Sunitinib to Australia?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 11 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Australia for Sunitinib?
The average transit time for Sunitinib shipments from India to Australia is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Sunitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.8% with demand growth tracking at 26.5%. The route is ranked #20 among India's top Sunitinib export destinations globally.
Q How many suppliers are active on the India to Australia Sunitinib route?
There are currently 3 active Indian suppliers exporting Sunitinib to Australia. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 53% of total shipment value.
Q Who are the main importers of Sunitinib from India in Australia?
The leading importers of Indian Sunitinib in Australia include SUN PHARMA ANZ PTY LTD , SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD, CIPLA AUSTRALIA PTY LTD. . SUN PHARMA ANZ PTY LTD is the largest buyer with 3 shipments worth $416.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Sunitinib.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 17 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists